Automation plays a crucial role in enhancing efficiency and increasing capacity for in vitro absorption, distribution, metabolism, and excretion profiling in early drug discovery. Building an automation platform requires a careful balance of innovation and practical considerations to align assay needs with technological capabilities. In this study, we present a state-of-the-art automation system designed to support the miniaturization of the Caco-2 permeability assay from the 24-well to the 96-well format. This platform integrates advanced infrastructure for cell culture and assay execution, along with several key features, including innovative cleaning protocols, cutting-edge plate tracking, and dynamic scheduling capabilities. The fully automated 96-well platform delivers significant efficiency gains, increased capacity, and faster turnaround for permeability assay support while maintaining high predictive accuracy. It correctly classified 94% of 50 literature compounds, demonstrating strong concordance with the established 24-well format. Moreover, the platform enables large-scale permeability data generation, advancing our “predict-first” modeling paradigm, in which predictive models guide experimental design and compound prioritization.
HughesJP, ReesS, KalindjianSB, et al.Principles of early drug discovery. Br J Pharmacol, 2011; 162(6):1239–1249; doi: 10.1111/j.1476-5381.2010.01127.x
2.
LiuJH, VernikovskayaD, BoraG, et al.Novel multiplexed high throughput screening of selective inhibitors for drug-metabolizing enzymes using human hepatocytes. Aaps J, 2024; 26(3):36; doi: 10.1208/s12248-024-00908-8
3.
ShouWZ. Current status and future directions of high-throughput ADME screening in drug discovery. J Pharm Anal, 2020; 10(3):201–208; doi: 10.1016/j.jpha.2020.05.004
WangY-T, MaesEM, HeinleL, et al.Integrity and efficiency: AbbVie’s journey of building an integrated nonregulated bioanalytical laboratory. Bioanalysis, 2023; 15(3):161–176; doi: 10.4155/bio-2023-0012
6.
SantiagoBG, EisennagelSH, PeckhamGE, et al.Perspective on high-throughput bioanalysis to support in vitro assays in early drug discovery. Bioanalysis, 2023; 15(3):177–191; doi: 10.4155/bio-2022-0207
7.
ShahP, JoganiV, BagchiT, et al.Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol Prog, 2006; 22(1):186–198; doi: 10.1021/bp050208u
8.
ArturssonP, PalmK, LuthmanK. Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996). Adv Drug Deliv Rev, 2001; 46(1–3):27–43; doi: 10.1016/S0169-409x(00)00128-9
9.
MeunierV, BourrieM, BergerY, et al.The human intestinal epithelial-cell line CACO-2 - pharmacological and pharmacokinetic applications. Cell Biol Toxicol, 1995; 11(3–4):187–194; doi: 10.1007/bf00756522
10.
LarsonB, BanksP, ShermanH, et al.Automation of cell-based drug absorption assays in 96-well format using permeable support systems. J Lab Autom, 2012; 17(3):222–232; doi: 10.1177/2211068211428190
11.
SkolnikS, LinXN, WangJL, et al.Towards prediction of in vivo intestinal absorption using a 96-Well Caco-2 assay. J Pharm Sci, 2010; 99(7):3246–3265; doi: 10.1002/jps.22080
12.
CaiXM, PatelS, HuangCL, et al.Comprehensive characterization and optimization of Caco-2 cells enabled the development of a miniaturized 96-well permeability assay. Xenobiotica, 2022; 52(7):742–750; doi: 10.1080/00498254.2022.2133648
13.
CaiXM, WalkerA, ChengC, et al.Approach to improve compound recovery in a high-throughput Caco-2 permeability assay supported by liquid chromatography-tandem mass spectrometry. J Pharm Sci, 2012; 101(8):2755–2762; doi: 10.1002/jps.23194
14.
CaiXM, MadariS, WalkerA, et al.Addition of optimized bovine serum albumin level in a high-throughput Caco-2 assay enabled accurate permeability assessment for lipophilic compounds. SLAS Discov, 2019; 24(7):738–744; doi: 10.1177/2472555219848483
15.
ZhangJ, VathM, FerraroC, et al.A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening. Rapid Commun Mass Spectrom, 2013; 27(7):731–737; doi: 10.1002/rcm.6514
16.
ZhangHLJ, et al.An Automated Platform for LC/MS/MS Methods Development, Storage and Distribution. Indianapolis, IN; 2017.
17.
WernevikJ, BergströmF, NovénA, et al.A fully integrated assay panel for early drug metabolism and pharmacokinetics profiling. Assay Drug Dev Technol, 2020; 18(4):157–179; doi: 10.1089/adt.2020.970
18.
EkinsS, PuhlAC, ZornKM, et al.Exploiting machine learning for end-to-end drug discovery and development. Nat Mater, 2019; 18(5):435–441; doi: 10.1038/s41563-019-0338-z
19.
Di LascioE, GerebtzoffG, Rodríguez-PérezR. Systematic evaluation of local and global machine learning models for the prediction of ADME properties. Mol Pharm, 2023; 20(3):1758–1767; doi: 10.1021/acs.molpharmaceut.2c00962
20.
FangC, WangY, GraterR, et al.Prospective validation of machine learning algorithms for absorption, distribution, metabolism, and excretion prediction: An industrial perspective. J Chem Inf Model, 2023; 63(11):3263–3274; doi: 10.1021/acs.jcim.3c00160
21.
WeissDR, BortolatoA, SunYN, et al.On ternary complex stability in protein degradation: In silico molecular glue binding affinity calculations. J Chem Inf Model, 2023; 63(8):2382–2392; doi: 10.1021/a8cs.jcim.2c01386
